Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

PULMONX Earnings Results: $LUNG Reports Quarterly Earnings

None

PULMONX ($LUNG) posted quarterly earnings results on Wednesday, November 12th. The company reported earnings of -$0.34 per share, beating estimates of -$0.43 by $0.09. The company also reported revenue of $21,500,000, beating estimates of $21,285,696 by $214,304.

You can see Quiver Quantitative's $LUNG stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

PULMONX Insider Trading Activity

LUNG Insider Trades

PULMONX insiders have traded $LUNG stock on the open market 28 times in the past 6 months. Of those trades, 1 have been purchases and 27 have been sales.

Here’s a breakdown of recent trading of $LUNG stock by insiders over the last 6 months:

  • DANIEL P FLORIN purchased 23,321 shares for an estimated $71,362
  • DAVID AARON LEHMAN (GENERAL COUNSEL) has made 0 purchases and 9 sales selling 20,226 shares for an estimated $48,366.
  • STEVEN S. WILLIAMSON (PRESIDENT AND CEO) has made 0 purchases and 4 sales selling 19,571 shares for an estimated $46,495.
  • MEHUL JOSHI (Chief Financial Officer & PAO) has made 0 purchases and 4 sales selling 15,997 shares for an estimated $37,928.
  • GEOFFREY BERAN ROSE (CHIEF COMMERCIAL OFFICER) has made 0 purchases and 9 sales selling 13,490 shares for an estimated $32,216.
  • RICHARD FERRARI sold 8,000 shares for an estimated $25,280

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

PULMONX Hedge Fund Activity

We have seen 55 institutional investors add shares of PULMONX stock to their portfolio, and 65 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PULMONX Government Contracts

We have seen $292,066 of award payments to $LUNG over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

PULMONX Analyst Ratings

Wall Street analysts have issued reports on $LUNG in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • D. Boral Capital issued a "Buy" rating on 10/28/2025
  • Stifel issued a "Buy" rating on 07/31/2025
  • Lake Street issued a "Buy" rating on 07/31/2025

To track analyst ratings and price targets for PULMONX, check out Quiver Quantitative's $LUNG forecast page.

PULMONX Price Targets

Multiple analysts have issued price targets for $LUNG recently. We have seen 6 analysts offer price targets for $LUNG in the last 6 months, with a median target of $4.075.

Here are some recent targets:

  • Jason Kolbert from D. Boral Capital set a target price of $14.0 on 10/28/2025
  • Frank Takkinen from Lake Street set a target price of $4.0 on 10/28/2025
  • Larry Biegelsen from Wells Fargo set a target price of $3.0 on 08/01/2025
  • Rick Wise from Stifel set a target price of $5.0 on 07/31/2025
  • Jason Bednar from Piper Sandler set a target price of $2.5 on 07/31/2025
  • Joanne Wuensch from Citigroup set a target price of $4.15 on 05/22/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles